Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar ebitdat (< 20) Submitted: 9/23/2010 10:45:28 AM : Outperform Start Price: $3.52 ALXA Score: -106.56

Betting on approval

Featured Broker Partners


Advertisement